News and Announcements
US FDA approves new format of GSK's Shingrix
By Josh White
Date: Thursday 17 Jul 2025
(Sharecast News) - GSK announced on Thursday that it has received approval from the US Food and Drug Administration for a new prefilled syringe presentation of its shingles vaccine, Shingrix.
The FTSE 100 company said the change eliminated the need for reconstitution prior to administration, streamlining the process for healthcare providers.
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
Article Archive
You are here: news
